Mera Pharmaceuticals, Inc. (MRPI)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 28, 16:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 0.0557M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 9.90K% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | -- |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -- |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 100.00% |
Profile
| Mera Pharmaceuticals, Inc. is a marine biotechnology company. It engages in the provision of photobioreactor technology and owns extensive intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The company was founded in 1987 and is headquartered in Las Vegas, NV. |
| URL | http://www.merapharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Nevada |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Mera Pharmaceuticals, Inc. is a marine biotechnology company. It engages in the provision of photobioreactor technology and owns extensive intellectual property dedicated to the culture of microalgae for biofuel or nutriceutical production. The company was founded in 1987 and is headquartered in Las Vegas, NV. |
| URL | http://www.merapharma.com |
| Investor Relations URL | N/A |
| HQ State/Province | Nevada |
| Sector | Health Care |
| Industry | Biotechnology |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
